EUVIMEDEUVIMED entdecken
Crossref

Ocular Considerations for the Department of War’s New Testosterone Initiative

Carson E Clabeaux iD, Maxim Narduzzi, Harkaran S Rana iD

Military Medicine · 03.11.2026

DOI: 10.1093/milmed/usag503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, online erschienen am 03.11.2026. Verfasst von Carson E Clabeaux und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Uniformed Services University, Bethesda, MD, United States. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On 15 July 2026, the Secretary of War announced that the Department of War will begin annual testosterone deficiency screening for male Active Duty and Reserve Component personnel aged 30 and older as part of the periodic health assessment, with screening available on request to younger servicemembers. This policy will increase testosterone testing and may increase testosterone replacement therapy (TRT). Primary care, flight, and operational medicine providers will be on the front line of a hormonal intervention with possible ocular implications. This Commentary summarizes the ophthalmic manifestations of low and elevated testosterone states relevant to a military population and proposes pragmatic recommendations for providers implementing this initiative. Screening identifies testosterone concentrations, not symptoms of deficiency, and should not be equated with an indication for treatment. Androgen deficiency is associated with meibomian gland dysfunction and evaporative dry eye, but benefit from replacement remains unproven. The evidence linking testosterone exposure to central serous chorioretinopathy, retinal vascular occlusion, and intracranial hypertension is real but heterogeneous. Cohort findings, case reports, and observations in transgender patients do not establish a common risk in hypogonadal male servicemembers. Glaucoma findings are similarly mixed. We propose a brief, targeted ocular history, symptom counseling and inquiry during TRT follow-up and periodic health assessments, and referral according to clinical urgency. For vision-critical specialties, baseline dilated examination should be coordinated through existing occupational clearance processes when an adequate recent examination is unavailable. These measures are precautionary; screening benefit and an optimal repeat-examination interval have not been established. The Military Health System is uniquely positioned to prospectively answer the ocular questions this literature has only partially resolved.

Autor:innen und Institutionen

  • Department of Surgery, Uniformed Services University, Bethesda, MD, United States.
  • Department of Surgery, Evans Army Community Hospital, Fort Carson, CO, United States.
  • New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States.
  • Department of Ophthalmology, Madigan Army Medical Center, Tacoma, WA, United States.

ORCID-Profile: Carson E Clabeaux, Harkaran S Rana

Zitieren

APA

Clabeaux, C. E., Narduzzi, M., & Rana, H. S. (2026). Ocular Considerations for the Department of War’s New Testosterone Initiative. Military Medicine. https://doi.org/10.1093/milmed/usag503

Vancouver

Clabeaux CE, Narduzzi M, Rana HS. Ocular Considerations for the Department of War’s New Testosterone Initiative. Military Medicine. 2026. doi:10.1093/milmed/usag503

BibTeX
@article{Clabeaux2026,
  author = {Clabeaux, Carson E and Narduzzi, Maxim and Rana, Harkaran S},
  title = {Ocular Considerations for the Department of War’s New Testosterone Initiative},
  journal = {Military Medicine},
  year = {2026},
  doi = {10.1093/milmed/usag503}
}
Kostenlos starten →